However, dual loss of Trp53 and Nf2 resulted in cancers that were highly aggressive and invasive, which had a median survival of 14 days compared with 39 and 41 days in singular Nf2-deleted and Trp53-deleted tumors, respectively (Fig. 3A). The gene discussed is TP53; the disease is cancer.